000 01636 a2200457 4500
005 20250516032656.0
264 0 _c20110614
008 201106s 0 0 eng d
022 _a1527-3350
024 7 _a10.1002/hep.24189
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMakowska, Zuzanna
245 0 0 _aInterferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo.
_h[electronic resource]
260 _bHepatology (Baltimore, Md.)
_cApr 2011
300 _a1154-63 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Line, Tumor
650 0 4 _aCytokines
_xphysiology
650 0 4 _aEndopeptidases
_xmetabolism
650 0 4 _aHepatitis C, Chronic
_xphysiopathology
650 0 4 _aHumans
650 0 4 _aInterferon Inducers
_xpharmacology
650 0 4 _aInterferon-alpha
_xpharmacology
650 0 4 _aInterferon-beta
_xpharmacology
650 0 4 _aInterferon-gamma
_xpharmacology
650 0 4 _aIntestine, Small
_xdrug effects
650 0 4 _aJanus Kinases
_xmetabolism
650 0 4 _aLiver
_xdrug effects
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aSTAT1 Transcription Factor
_xmetabolism
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aUbiquitin Thiolesterase
700 1 _aDuong, Francois H T
700 1 _aTrincucci, Gaia
700 1 _aTough, David F
700 1 _aHeim, Markus H
773 0 _tHepatology (Baltimore, Md.)
_gvol. 53
_gno. 4
_gp. 1154-63
856 4 0 _uhttps://doi.org/10.1002/hep.24189
_zAvailable from publisher's website
999 _c20747209
_d20747209